Estratificación de la gravedad del síndrome de insuficiencia respiratoria aguda a las 24 horas de su diagnóstico

Q4 Medicine
M. D. J. Sánchez-Zúñiga, R. Carrillo-Esper, M. Garnica-Escamilla, Nikolette Iren Medveczky-Ordoñes, D. M. Carrillo-Córdova
{"title":"Estratificación de la gravedad del síndrome de insuficiencia respiratoria aguda a las 24 horas de su diagnóstico","authors":"M. D. J. Sánchez-Zúñiga, R. Carrillo-Esper, M. Garnica-Escamilla, Nikolette Iren Medveczky-Ordoñes, D. M. Carrillo-Córdova","doi":"10.24245/mim.v35i1.2120","DOIUrl":null,"url":null,"abstract":"OBJECTIVE: To identify if there are changes in the stratification of acute respiratory distress syndrome severity at hospitalization and 24 hours later. MATERIAL AND METHOD: A retrospective observational study was done describing patients studied over a 4-month period during 2017, who met Berlin criteria for acute respiratory distress syndrome (ARDS) of any origin and who re-stratified at 24 hours, with the same scale. The data of inflammatory biomarkers and ventilatory mechanics were collected. RESULTS: There were included 17 patients, from which 11 patients (64%) died and 6 (35%) were discharged to home. The initial stratification of patients according to the severity of the hypoxemia (PaO2/FiO2) showed 2 (11%) without ARDS, 3 (17%) mild, 10 (58%) moderate, and 2 (11%) severe. At 24 hours after conventional treatment, gravity stratification (PaO2/FiO2) showed: 9 (52%) without ARDS, 6 (35.2%) with mild hypoxemia, in one (5.8%) moderate and in one (5.8%) severe. CONCLUSIONS: It is necessary to stratify at the time of admission and at 24 hours the severity of the ARDS, although no difference was shown in the pattern of inflammatory response through the measurement of serum markers of usual clinical use.","PeriodicalId":35750,"journal":{"name":"Medicina Interna de Mexico","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2019-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medicina Interna de Mexico","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.24245/mim.v35i1.2120","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

OBJECTIVE: To identify if there are changes in the stratification of acute respiratory distress syndrome severity at hospitalization and 24 hours later. MATERIAL AND METHOD: A retrospective observational study was done describing patients studied over a 4-month period during 2017, who met Berlin criteria for acute respiratory distress syndrome (ARDS) of any origin and who re-stratified at 24 hours, with the same scale. The data of inflammatory biomarkers and ventilatory mechanics were collected. RESULTS: There were included 17 patients, from which 11 patients (64%) died and 6 (35%) were discharged to home. The initial stratification of patients according to the severity of the hypoxemia (PaO2/FiO2) showed 2 (11%) without ARDS, 3 (17%) mild, 10 (58%) moderate, and 2 (11%) severe. At 24 hours after conventional treatment, gravity stratification (PaO2/FiO2) showed: 9 (52%) without ARDS, 6 (35.2%) with mild hypoxemia, in one (5.8%) moderate and in one (5.8%) severe. CONCLUSIONS: It is necessary to stratify at the time of admission and at 24 hours the severity of the ARDS, although no difference was shown in the pattern of inflammatory response through the measurement of serum markers of usual clinical use.
急性呼吸衰竭综合征诊断后24小时的严重程度分层
目的:确定急性呼吸窘迫综合征住院时和24小时后的严重程度分层是否有变化。材料和方法:一项回顾性观察性研究描述了2017年4个月期间研究的患者,这些患者符合任何来源的急性呼吸窘迫综合征(ARDS)的柏林标准,并在24小时内以相同的量表重新分层。收集炎症生物标志物和通气力学数据。结果:纳入17例患者,其中死亡11例(64%),出院6例(35%)。根据低氧血症(PaO2/FiO2)严重程度对患者进行初始分层,无ARDS 2例(11%),轻度3例(17%),中度10例(58%),重度2例(11%)。常规治疗后24 h,重力分层(PaO2/FiO2)结果显示:无ARDS 9例(52%),轻度低氧血症6例(35.2%),中度低氧血症1例(5.8%),重度低氧血症1例(5.8%)。结论:在入院时和24小时时对ARDS的严重程度进行分层是必要的,尽管通过常规临床使用的血清标志物测量炎症反应模式没有显示出差异。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Medicina Interna de Mexico
Medicina Interna de Mexico Medicine-Internal Medicine
CiteScore
0.30
自引率
0.00%
发文量
137
期刊介绍: La revista Medicina Interna de México es el órgano oficial del Colegio de Medicina Interna de México Reserva de Titulo de la Dirección General del Derecho de Autor (SEP) número 04-2001-112110545900.-102 certificado de Licitud de Titulo número 11967 y Certilicado de Licitud de Contenido de la Comisión Catificadora de Publicaciones y Revistas Ilustradas (SeGob) número 8375. AutorIzada por SEPOMEX como Publicación Penódica Registro número PPO9- 0884
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信